Zyxin (ZYX) Peptide
ZYX
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN987256
Aperçu rapide pour Zyxin (ZYX) Peptide (ABIN987256)
Antigène
ZYX
(Zyxin (ZYX))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-ZYX antibody (Catalog #: ARP34387_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ZYX (Zyxin (ZYX))
-
Sujet
-
Focal adhesions are actin-rich structures that enable cells to adhere to the extracellular matrix and at which protein complexes involved in signal transduction assemble. Zyxin is a zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin may function as a messenger in the signal transduction pathway that mediates adhesion-stimulated changes in gene expression and may modulate the cytoskeletal organization of actin bundles.
Alias Symbols: ESP-2, HED-2
Protein Interaction Partner: ACTN1,ATXN1,BSPRY,ENAH,HIPK3,LASP1,LATS1,NEBL,NEDD9,RPH3AL,TES,VASP,VAV1,VAV3,ZNF384,ACTN1,BCAR1,ENAH,LASP1,LATS1,NEBL,NEDD9,TES,VASP,ZHX1
Protein Size: 572 -
Poids moléculaire
- 61 kDa
-
ID gène
- 7791
-
NCBI Accession
- NM_003461, NP_003452
-
UniProt
- Q15942
Antigène
-
Vous êtes ici:
